These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 494377

  • 1. Effect of ureteral ligation and nephrectomy on granulocyte-macrophage progenitor cells and azathioprine toxicity.
    Gamelli RL, Foster RS.
    Transplantation; 1979 Sep; 28(3):183-5. PubMed ID: 494377
    [Abstract] [Full Text] [Related]

  • 2. Increased azathioprine toxicity after ureteral ligation and nephrectomy.
    Gamelli RL, Foster RS.
    Surg Forum; 1978 Sep; 29():358-9. PubMed ID: 401186
    [No Abstract] [Full Text] [Related]

  • 3. Hematopoietic toxicity by cimetidine. Reexamination using the antimetabolite azathioprine.
    Gamelli RL, Foster RS, Whisnant JK.
    Transplantation; 1983 Jan; 35(1):12-4. PubMed ID: 6823692
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Acute and chronic dose/response effects of inhaled benzene on multipotential hematopoietic stem (CFU-S) and granulocyte/macrophage progenitor (GM-CFU-C) cells in CD-1 mice.
    Green JD, Snyder CA, LoBue J, Goldstein BD, Albert RE.
    Toxicol Appl Pharmacol; 1981 May; 58(3):492-503. PubMed ID: 7245216
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
    Ido M, Harada M, Furuichi H, Matsuoka N, Nakano K, Sohmura Y.
    Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
    [Abstract] [Full Text] [Related]

  • 7. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V.
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [Abstract] [Full Text] [Related]

  • 8. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
    Song H, Vita M, Sallam H, Tehranchi R, Nilsson C, Sidén A, Hassan Z.
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617
    [Abstract] [Full Text] [Related]

  • 9. Altered toxicity of 5-fluorouracil following treatment with Corynebacterium parvum.
    Foster RS.
    Cancer Res; 1978 Mar; 38(3):850-8. PubMed ID: 304762
    [Abstract] [Full Text] [Related]

  • 10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ, Ratajczak J, Kuczynski W, Light B, Lusk EJ, Gewirtz AM.
    Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
    [Abstract] [Full Text] [Related]

  • 13. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
    Güenechea G, Bueren JA, Maganto G, Tuduri P, Guerrero A, Pivel JP, Real A.
    Stem Cells; 1995 Mar; 13(2):175-85. PubMed ID: 7540471
    [Abstract] [Full Text] [Related]

  • 14. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 15. A new experimental protocol as an alternative to the colony-forming unit-granulocyte/macrophage (CFU-GM) clonogenic assay to assess the haematotoxic potential of new drugs.
    Dal Negro G, Vandin L, Bonato M, Repeto P, Sciuscio D.
    Toxicol In Vitro; 2006 Aug; 20(5):750-6. PubMed ID: 16321498
    [Abstract] [Full Text] [Related]

  • 16. A gene-controlling response of bone marrow progenitor cells to granulocyte-macrophage colony stimulating factors.
    Lazar GS, Quon DH, Lusis AJ.
    J Cell Physiol; 1985 Aug; 124(2):293-8. PubMed ID: 3876341
    [Abstract] [Full Text] [Related]

  • 17. Toward refinement of the colony-forming unit-granulocyte/macrophage clonogenic assay: inclusion of a metabolic system.
    Dal Negro G, Vandin L, Bonato M, Sciuscio D.
    Toxicol In Vitro; 2006 Aug; 20(5):743-9. PubMed ID: 16324821
    [Abstract] [Full Text] [Related]

  • 18. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM).
    Grant S, Pettit GR, McCrady C.
    Exp Hematol; 1992 Jan; 20(1):34-42. PubMed ID: 1374343
    [Abstract] [Full Text] [Related]

  • 19. Effect of azimexon (BM 12.531) on mouse granulocyte-macrophage and monocyte-macrophage progenitor cells.
    Jeng JC, McCarthy KF, Chirigos MA, Weiss JF.
    Experientia; 1982 Jan 15; 38(1):132-4. PubMed ID: 7056357
    [Abstract] [Full Text] [Related]

  • 20. The proliferative states of density subpopulations of granulocyte-macrophage progenitor cells.
    Byrne PV, Heit W, Kubanek B.
    Exp Hematol; 1979 Feb 15; 7(2):105-12. PubMed ID: 311738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.